Objective Countries routinely offering acellular pertussis vaccine, where long-term protection
is not sustained, have the challenge of selecting an optimal schedule to minimise disease …

A key goal of pertussis control is to protect infants too young to be vaccinated, the age group
most vulnerable to this highly contagious respiratory infection. In the last decade, maternal …

Prenatal maternal immunization is an effective tool to protect mothers and infants from poor
health outcomes due to infectious diseases. We provide an overview of the rationale for the …

SpikoGen® is a recombinant spike protein vaccine against COVID-19 that obtained
marketing authorization in the Middle East on October 6 th, 2021, becoming the first …

Pertussis vaccination during pregnancy has been implemented in many highresource
countries. Recent data from the United States, the United Kingdom, and South America …

Background Maternal pertussis vaccination during the third trimester of pregnancy was
implemented in 2015 in Spain, reaching a national coverage of 84% in 2019. In this …

Objectives: Estimates of vaccination coverage during pregnancy and identification of
disparities in vaccination coverage can inform vaccination campaigns and programs. We …

Background Pertussis is a contagious respiratory disease. Maternal tetanus–diphtheria–
acellular pertussis vaccination during pregnancy has been recommended by the United …

Objective The purpose of this study was to measure the proportion of non-vaccination for
pertussis in mothers in Canada who had been advised by their prenatal care provider to get …

Respiratory syncytial virus (RSV) is, in addition to SARS-CoV-2 and influenza, one of the
most important respiratory pathogens affecting women's health. Although RSV typically …